Stay updated on Nivolumab Safety in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Safety in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Safety in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The Nivolumab study record is now displayed, including its completed status, eligibility criteria, study locations, and safety and efficacy outcome measures.
    Difference
    53%
    Check dated 2026-11-08T02:28:49.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer now shows site revision v3.8.0 instead of v3.7.2; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T22:30:37.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A sitewide banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T22:32:50.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer’s site revision label was updated from v3.7.1 to v3.7.2; the study record remains inaccessible on this page.
    Difference
    0.2%
    Check dated 2026-10-17T22:42:47.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:29:08.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the expected content, indicating the record is temporarily inaccessible.
    Difference
    18%
    Check dated 2026-09-19T22:15:41.000Z thumbnail image

Stay in the know with updates to Nivolumab Safety in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Safety in Lung Cancer Clinical Trial page.